B H Ch Stricker
Overview
Explore the profile of B H Ch Stricker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Hunsel F, van Nieuwkoop C, Stricker B
Ned Tijdschr Geneeskd
. 2017 Sep;
161:D1477.
PMID: 28880141
Clioquinol is used for treatment of amoebiasis and infection with Dientamoeba fragilis. In a guideline of the Dutch Working Party on Antibiotic Policy, clioquinol is recommended as a first-choice treatment...
2.
Cheung K, El Marroun H, Elfrink M, Jaddoe V, Visser L, Stricker B
Pharmacoepidemiol Drug Saf
. 2017 Jul;
26(9):1119-1125.
PMID: 28744981
Purpose: Several studies have been conducted to assess determinants affecting the performance or accuracy of self-reports. These studies are often not focused on pregnant women, or medical records were used...
3.
Clockaerts S, van Osch G, Bastiaansen-Jenniskens Y, Verhaar J, Van Glabbeek F, van Meurs J, et al.
Ann Rheum Dis
. 2011 Oct;
71(5):642-7.
PMID: 21989540
Background: Osteoarthritis is the most frequent chronic joint disease causing pain and disability. Besides biomechanical mechanisms, the pathogenesis of osteoarthritis may involve inflammation, vascular alterations and dysregulation of lipid metabolism....
4.
Ruiter R, Visser L, van Herk-Sukel M, Coebergh J, Haak H, Geelhoed-Duijvestijn P, et al.
Diabetologia
. 2011 Sep;
55(1):51-62.
PMID: 21956710
Aims/hypothesis: Several publications suggest an association between certain types of insulin and cancer, but with conflicting results. We investigated whether insulin glargine (A21Gly,B31Arg,B32Arg human insulin) is associated with an increased...
5.
Incidence, treatment, and case-fatality of non-traumatic subarachnoid haemorrhage in the Netherlands
Risselada R, de Vries L, Dippel D, van Kooten F, van der Lugt A, Niessen W, et al.
Clin Neurol Neurosurg
. 2011 Mar;
113(6):483-7.
PMID: 21420782
Background: Non-traumatic subarachnoid haemorrhage (SAH) is a devastating disorder and in the majority of cases it is caused by rupture of an intracranial aneurysm. No actual data are available on...
6.
Stricker B, Stijnen T
Eur J Epidemiol
. 2010 Apr;
25(4):245-51.
PMID: 20358262
In pharmaco-epidemiology, the use of drugs is the determinant of interest when studying exposure-outcome associations. The increased availability of computerized information about drug use on an individual basis has greatly...
7.
de Keyser C, Eijgelsheim M, Hofman A, Sijbrands E, Maitland-van der Zee A, van Duijn C, et al.
Pharmacogenomics J
. 2010 Mar;
11(1):72-80.
PMID: 20195290
The objective of this study was to investigate whether common variation in genes involved in lipid metabolism modify the effect of statins on serum total cholesterol concentration. Statin users were...
8.
Van Durme Y, Eijgelsheim M, Joos G, Hofman A, Uitterlinden A, Brusselle G, et al.
Eur Respir J
. 2009 Dec;
36(1):89-95.
PMID: 19996190
The Hedgehog signalling pathway plays an important role in lung morphogenesis and cellular responses to lung injury. A genome-wide association study has demonstrated that two single nucleotide polymorphisms (SNPs) near...
9.
Voordouw A, Beyer W, Smith D, Sturkenboom M, Stricker B
Vaccine
. 2009 Nov;
28(2):392-7.
PMID: 19878750
Background: As part of the regulatory requirements, serological evaluation of trivalent inactivated influenza vaccines must be performed before annual re-licensure in the European Union. These studies are typically set up...
10.
Siemes C, Eijgelsheim M, Dieleman J, van Schaik R, Uitterlinden A, van Duijn C, et al.
Neth J Med
. 2009 Jul;
67(4):134-41.
PMID: 19581657
Background: CYP2C9 enzymes are involved in non-steroidal anti-inflammatory drug (NSAID) metabolism. Therefore, we investigated whether CYP2C9*2 and *3 variant alleles, encoding for enzymes with lower activity, increased the protective effect...